Close
×
Subscribe Now
By entering these details you are signing up to receive our newsletter.
First Name
Last Name
Your Email
Type of visitor?
Individuals with a rare condition
Caregiver/family member
Industry/biotech/pharma
Healthcare professionals
Charity/advocate
General interest
Newsletters
RAREBite Newsletter Subscribers (Twice Weekly)
Magazine and RARE Round-Up Weekly Newsletter
Latest Edition
RARE Neurology
Subscribe Now
Home
Meet the team
Magazine
RARE INSIGHTS
A day in the life
Charity & advocacy
Charity partner news
Editor’s picks
Events
Industry insights
Medical
Patient voice
Press releases
RARE employment
RARE parenting
RARE ramblings
RARE REV-inar
Science & tech
Sunday sessions
Turning the tide for rare disease
Weblinks and references
THE PEOPLE OF RARE
Digital Spotlight
Resources
RARE Reports
Charity Partners
Charity Signup
WORK WITH US
Rare Revolutionaries
Corporate Friends
Community Gallery
Rare Youth
Privacy Policy
Latest Edition
RARE Neurology
Subscribe Now
To use more accessibility options, please use a different browser such as Chrome or Firefox.
Medical
Medical
The GLISTEN trial
By Rebecca Pender
14 April 2023
Medical
CATNAP® registry: collecting real-world data to enhance understanding of paediatric narcolepsy
By Rebecca Pender
17 November 2022
Medical
Sanius Health’s mission to personalise care for people with sickle cell disease—using advanced wearable technology
By Rebecca Pender
29 September 2022
Medical
The RAPSODI study: an online study to understand the association between the Gaucher-causing gene and Parkinson’s
By Rebecca Pender
14 September 2022
Medical
Intrahepatic cholestasis of pregnancy: a rare liver disorder that causes risk to unborn babies—the unique insights of Dr Laura Bonebrake, physician and ICP mother
By Rebecca Pender
29 June 2022
Medical
Inozyme Pharma: developing therapies for abnormal mineralisation disorders
By Rebecca Pender
9 June 2022
Medical
Seeing Red
By Rebecca Pender
26 November 2021
Medical
Zebras do exist: the diagnostic odyssey of rare disease patients
By Rebecca Pender
13 July 2021
Medical
Phase 3 ‘Proof-HD’ trial begins in Europe for people with Huntington disease
By Rebecca Pender
28 January 2021
Medical
UK’s largest ever NHS rare disease diagnosis programme launched by Mendelian and Modality NHS Partnership
By Rebecca Pender
17 December 2020
Medical
Anavex Life Sciences is the company to learn from according to the rare disease advocacy community
By Rebecca Pender
16 December 2020
Medical
Alan Finglas, founder of MSD Action Foundation and Saving Dylan, contemplates EU policy and the potential it has to open the gates for real change in the rare disease community
By Rebecca Pender
28 July 2020
Medical
Why the COVID-19 pandemic may be particularly challenging for families living with rare conditions
By Rebecca Pender
17 July 2020
Medical
My reflections on COVID-19
By Rebecca Pender
10 July 2020
Medical
Danny’s Dose changing rules and saving lives
By Rebecca Pender
12 June 2020
Medical
With these feet? – A spotlight on young onset Parkinson’s disease
By Rebecca Pender
14 April 2020
Medical
Healx using artificial intelligence to find combination drug treatments for COVID-19
By Rebecca Pender
6 April 2020
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset